Outcomes | No. Included Studies | No. TKAs | MD/OR (95% CI) | Heterogeneity | |
---|---|---|---|---|---|
F TB | A CB | ||||
Single short FTB vs. ACB | |||||
 Pain score with rest at 24 h | 2 | 73 | 73 | -0.84(-1.10,-0.58) | I2 = 0%, P < 0.001 |
 Pain score with activity at 24 h | 2 | 73 | 73 | -0.81(-1.03,-0.59) | I2 = 0%, P < 0.001 |
 Pain score with rest at 48 h | 2 | 73 | 73 | -0.04(-0.23,0.15) | I2 = 64%, P = 0.66 |
 Pain score with activity at 48 h | 2 | 73 | 73 | -0.22(-0.44,0.00) | I2 = 0%, P = 0.06 |
 Adverse reaction incidence rate | 3 | 114 | 114 | 0.800(0,1)0.42.54 | I2 = 0%, P = 0.51 |
Continuous FTB vs.ACB with catheter | |||||
 Pain score with rest at 24 h | 2 | 71 | 71 | 0.74(0.50,0.99) | I2 = 0%, P < 0.001 |
 Pain score with activity at 24 h | 2 | 71 | 71 | 0.780(0,1)0.53.03 | I2 = 0%, P < 0.001 |
 Pain score with rest at 48 h | 2 | 71 | 71 | 0.460(0,0)0.29.63 | I2 = 84%, P < 0.001 |
 Pain score with activity at 48 h | 2 | 71 | 71 | 0.28(0,0)0.12.44 | I2 = 97%, P < 0.001 |
 Postoperative satisfaction score | 2 | 71 | 71 | -0.99(-1.49,-0.49) | I2 = 70%, P < 0.001 |
 Adverse reaction incidence rate | 2 | 70 | 70 | 0.441(0,3)0.62.33 | I2 = 0%, P = 0.40 |